rs139245562

Variant summary

Our verdict is Likely benign. The variant received -5 ACMG points: 0P and 5B. BP4_StrongBS1_Supporting

The NM_032806.6(POMGNT2):​c.71G>A​(p.Arg24Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000436 in 1,608,896 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R24W) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.00043 ( 0 hom., cov: 33)
Exomes 𝑓: 0.00044 ( 0 hom. )

Consequence

POMGNT2
NM_032806.6 missense

Scores

4
14

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:7

Conservation

PhyloP100: 1.33

Publications

5 publications found
Variant links:
Genes affected
POMGNT2 (HGNC:25902): (protein O-linked mannose N-acetylglucosaminyltransferase 2 (beta 1,4-)) This gene encodes a protein with glycosyltransferase activity although its function is not currently known. [provided by RefSeq, Sep 2012]
POMGNT2 Gene-Disease associations (from GenCC):
  • muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 8
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, Genomics England PanelApp, G2P
  • myopathy caused by variation in POMGNT2
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • muscular dystrophy-dystroglycanopathy, type A
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -5 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.053028762).
BS1
Variant frequency is greater than expected in population amr. GnomAd4 allele frequency = 0.000427 (65/152284) while in subpopulation AMR AF = 0.00111 (17/15308). AF 95% confidence interval is 0.000707. There are 0 homozygotes in GnomAd4. There are 30 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_032806.6. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
POMGNT2
NM_032806.6
MANE Select
c.71G>Ap.Arg24Gln
missense
Exon 2 of 2NP_116195.2
POMGNT2
NM_001437285.1
c.71G>Ap.Arg24Gln
missense
Exon 3 of 3NP_001424214.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
POMGNT2
ENST00000344697.3
TSL:1 MANE Select
c.71G>Ap.Arg24Gln
missense
Exon 2 of 2ENSP00000344125.2Q8NAT1
POMGNT2
ENST00000441964.1
TSL:4
c.71G>Ap.Arg24Gln
missense
Exon 3 of 3ENSP00000408992.1Q8NAT1
POMGNT2
ENST00000686643.1
c.71G>Ap.Arg24Gln
missense
Exon 4 of 4ENSP00000509123.1Q8NAT1

Frequencies

GnomAD3 genomes
AF:
0.000427
AC:
65
AN:
152166
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000290
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00111
Gnomad ASJ
AF:
0.000288
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00949
Gnomad NFE
AF:
0.000426
Gnomad OTH
AF:
0.00143
GnomAD2 exomes
AF:
0.000338
AC:
82
AN:
242922
AF XY:
0.000242
show subpopulations
Gnomad AFR exome
AF:
0.0000641
Gnomad AMR exome
AF:
0.000730
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000434
Gnomad OTH exome
AF:
0.00134
GnomAD4 exome
AF:
0.000437
AC:
637
AN:
1456612
Hom.:
0
Cov.:
37
AF XY:
0.000407
AC XY:
295
AN XY:
724740
show subpopulations
African (AFR)
AF:
0.000209
AC:
7
AN:
33468
American (AMR)
AF:
0.000763
AC:
34
AN:
44570
Ashkenazi Jewish (ASJ)
AF:
0.0000384
AC:
1
AN:
26022
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39672
South Asian (SAS)
AF:
0.0000233
AC:
2
AN:
86014
European-Finnish (FIN)
AF:
0.0000202
AC:
1
AN:
49500
Middle Eastern (MID)
AF:
0.000706
AC:
4
AN:
5664
European-Non Finnish (NFE)
AF:
0.000488
AC:
542
AN:
1111450
Other (OTH)
AF:
0.000763
AC:
46
AN:
60252
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.488
Heterozygous variant carriers
0
38
75
113
150
188
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000427
AC:
65
AN:
152284
Hom.:
0
Cov.:
33
AF XY:
0.000403
AC XY:
30
AN XY:
74452
show subpopulations
African (AFR)
AF:
0.000289
AC:
12
AN:
41570
American (AMR)
AF:
0.00111
AC:
17
AN:
15308
Ashkenazi Jewish (ASJ)
AF:
0.000288
AC:
1
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5166
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4828
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10616
Middle Eastern (MID)
AF:
0.0102
AC:
3
AN:
294
European-Non Finnish (NFE)
AF:
0.000426
AC:
29
AN:
68006
Other (OTH)
AF:
0.00142
AC:
3
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
3
6
8
11
14
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000454
Hom.:
0
Bravo
AF:
0.000476
TwinsUK
AF:
0.000270
AC:
1
ALSPAC
AF:
0.00104
AC:
4
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000233
AC:
2
ExAC
AF:
0.000181
AC:
22
EpiCase
AF:
0.000763
EpiControl
AF:
0.000416

ClinVar

ClinVar submissions
Significance:Uncertain significance
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
3
-
not provided (3)
-
1
-
Inborn genetic diseases (1)
-
1
-
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 8 (1)
-
1
-
not specified (1)
-
1
-
POMGNT2-related disorder (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.085
BayesDel_addAF
Benign
-0.29
T
BayesDel_noAF
Benign
-0.28
CADD
Benign
23
DANN
Uncertain
1.0
DEOGEN2
Benign
0.013
T
Eigen
Benign
-0.15
Eigen_PC
Benign
0.0048
FATHMM_MKL
Uncertain
0.77
D
LIST_S2
Uncertain
0.91
D
M_CAP
Benign
0.049
D
MetaRNN
Benign
0.053
T
MetaSVM
Benign
-0.51
T
MutationAssessor
Benign
1.1
L
PhyloP100
1.3
PrimateAI
Benign
0.48
T
PROVEAN
Benign
0.20
N
REVEL
Benign
0.16
Sift
Uncertain
0.0090
D
Sift4G
Benign
0.24
T
Polyphen
0.17
B
Vest4
0.19
MVP
0.64
MPC
0.30
ClinPred
0.029
T
GERP RS
4.9
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.6
Varity_R
0.080
gMVP
0.48
Mutation Taster
=92/8
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs139245562; hg19: chr3-43122853; API